A STUDY TO ASSESS THE BIOEQUIVALENCE OF FIXED DOSE COMBINATION (FDC) TABLETS OF CANAGLIFLOZIN AND METFORMIN IMMEDIATE RELEASE (IR) WITH RESPECT TO THE INDIVIDUAL COMPONENTS OF CANAGLIFLOZIN AND METFORMIN IR TABLETS IN HEALTHY VOLUNTEERS: